DME Provider Enrollment in 2026: Annual Accreditation, Ownership Hurdles, and the New Moratorium
The regulatory landscape for Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) has undergone its most aggressive transformation in a decade. Navigating Medicare supplier enrollment and maintaining DMEPOS accreditation in 2026 requires more than just administrative diligence; it requires a proactive strategy to handle the new annual survey cycle and strict ownership rules. As of April 30, 2026, many suppliers are already feeling the pressure of the January 1st shifts, coupled with the nationwide moratorium that went into effect earlier this spring. If you are a DME provider, the "set it and forget it" mentality of the past is dead. The Veracity Group is tracking these developments in real-time to ensure your business remains compliant and your billing privileges remain active. Failure to adapt to these 2026 updates results in immediate deactivation, and in the current climate, getting back into the system is harder than ever. The Death of the Three-Year Cycle: Annual Accreditation is Here The most significant operational hurdle of 2026 is the shift from a three-year accreditation cycle to an annual accreditation survey requirement. Effective January 1, 2026, CMS replaced the 36-month accreditation cycle with an annual survey requirement, with AOs conducting unannounced inspections on a yearly basis. This means your business must now undergo an unannounced survey every single year to maintain Medicare billing privileges. This shift is designed to ensure that DMEPOS suppliers are consistently meeting the 30 Medicare Supplier Standards rather than "cleaning up" once every three years. For your facility, this means compliance must be a daily operational habit. The cost of failing an annual survey is steep: Revocation triggers a mandatory re-enrollment bar, often at least one year depending on the violation. Operational Impact of Annual Surveys Under the new rules, accreditation organizations (AOs) no longer provide the luxury of a wide window for inspections. You must have your records, inventory, and physical location ready for inspection at any moment. This includes: Verifiable proof of liability insurance that meets the $300,000 threshold. Documented evidence of oxygen-related training (if applicable). Stringent adherence to the 30 Supplier Standards, including the physical facility requirements. Looking for professional provider credentialing services in the USA? 👉 Check our main service page here: veracityeg.com The Expanded 36-Month Ownership Rule Strategic acquisitions and ownership transitions have become significantly more complex in 2026. As of January 1, 2026, the 36-Month Ownership Rule was expanded. If a DMEPOS supplier undergoes a change of ownership (CHOW) of more than 50% within 36 months of its initial enrollment or its last ownership change, the provider is typically required to undergo a full new initial enrollment rather than a simple change of information. This rule is a firewall against the "flipping" of DME providers and shell company schemes. If you are looking to purchase a DME business or bring on a majority partner, you must account for the reality that you will be treated as a brand-new applicant unless one of the narrow exceptions applies. Those exceptions are: Internal corporate restructuring where the entity remains under the same overall ownership. A change in business structure such as a corporation converting to an LLC, so long as the same owners remain in place. The death of an owner. It is also important to draw a hard line here: the "two consecutive years of cost reports" exception available to HHAs does not apply to DMEPOS suppliers. DME suppliers should not rely on that HHA exception when planning a transaction. If no exception applies, you must account for the reality that you will be treated as a brand-new applicant. This involves: Submitting a full CMS-855S application via PECOS 2.0. Paying the 2026 Medicare application fee of $750. Undergoing a new site visit and finger-print based background checks for all owners with 5% or more interest. The delay caused by a new initial enrollment can be six to nine months, during which time your ability to bill Medicare for new patients is effectively frozen. Understanding the compliance implications of your ownership structure is no longer optional; it is a matter of business survival. The 2026 Nationwide Moratorium: A Hard Stop for New Suppliers Effective February 27, 2026, CMS implemented a 6-month nationwide moratorium on seven specific categories of MSC-classified DMEPOS supplier types. This moratorium is a response to high levels of fraud and overutilization in these sectors. If you were planning to start a new business in any of these categories, your application will be denied or placed on hold until at least late August 2026, unless CMS extends the moratorium. The seven categories currently under the nationwide moratorium are: Medical Supply Company (MSC) Medical Supply Company with respiratory therapist Medical Supply Company with registered pharmacist Medical Supply Company with prosthetic and orthotic personnel Medical Supply Company with prosthetics personnel Medical Supply Company with pedorthic personnel Medical Supply Company with orthotics personnel While existing suppliers in these categories can continue to operate and undergo revalidation, they are under increased scrutiny. Any significant change in ownership or location for these providers could trigger a review that falls under the moratorium's restrictive umbrella. Financial Mandates: Fees and Surety Bonds in 2026 The cost of doing business with Medicare has increased. For the 2026 calendar year, the mandatory Medicare application fee is $750. This fee applies to all initial enrollments, revalidations, and certain changes of ownership. Furthermore, the $50,000 surety bond per NPI remains a non-negotiable barrier to entry and retention. If you operate multiple locations with separate NPIs, you must maintain a $50,000 bond for each. If your billing privileges have ever been revoked or you have been subject to a felony conviction, CMS may require an "elevated" bond amount, often exceeding $100,000. Maintaining your bond is critical. If your surety bond lapses for even a single day, the National Provider Enrollment (NPE) contractors are authorized to deactivate your billing privileges immediately. Navigating the NPE Contractors: East vs. West It is vital to remember that the National Supplier Clearinghouse (NSC) no longer exists. All DMEPOS enrollment functions are managed
Podiatry Credentialing: Navigating Medicare Carve-Outs and Commercial Panel Quirks in 2026
Navigating provider enrollment and medicare enrollment in 2026 is no longer a "set it and forget it" administrative task for podiatrists. As of April 30, 2026, the barrier to entry for commercial panels has tightened, and Medicare’s oversight of Routine Foot Care (RFC) has reached an all-time high. Your practice's ability to maintain its revenue stream depends entirely on how accurately you manage your enrollments and how strictly you adhere to the specific documentation requirements that trigger or prevent payment denials. Looking for professional provider credentialing services in the USA? 👉 Check our main service page here: veracityeg.com The 2026 Medicare Reimbursement Seesaw The 2026 Medicare Physician Fee Schedule introduces a complex balancing act for podiatric physicians. CMS has implemented modest adjustments to the conversion factor and efficiency offsets for 2026, resulting in relatively flat net reimbursement for podiatry. For a DPM, this means your gross revenue per claim remains relatively flat, making the cost of an enrollment error even more damaging to your bottom line. When managing your status in PECOS (Provider Enrollment, Chain, and Ownership System), precision is mandatory. For 2026, the Medicare application fee for institutional providers has been set at $750. However, individual DPMs enrolling in Part B typically do not pay this fee. The risk here isn't the cost of the application: it’s the cost of a "Deactivated" status. Medicare has shortened the response window for revalidation requests. If your revalidation is not completed within the strict 60-day window, your billing privileges will be deactivated, and Medicare will not backdate your coverage to cover the gap. The RFC Carve-Out: Surviving the 49% Non-Compliance Trap The 2025 Office of Inspector General (OIG) audit findings sent shockwaves through the podiatry community, revealing a staggering 49% non-compliance rate for Routine Foot Care (RFC) claims. As we move through 2026, Medicare Administrative Contractors (MACs) are using these findings to justify increased Pre-Payment Reviews and Targeted Probe and Educate (TPE) audits. The "carve-out" for RFC is a regulatory minefield. Medicare generally excludes coverage for routine foot care, but exceptions exist for patients with systemic conditions like diabetes or peripheral vascular disease. To secure payment for CPT codes 11055, 11056, 11057 (treatment of lesions) and 11719 (trimming of nails), your enrollment profile must correctly reflect your specialty and your documentation must prove medical necessity through "Class Findings." Actionable Strategy: Documenting Class Findings To survive a compliance audit in 2026, your notes must capture the specific clinical indicators that lift the RFC exclusion: Class A Findings: Non-traumatic amputation of foot or integral skeletal portion. Class B Findings: Absent posterior tibial pulse; advanced trophic changes (hair growth, nail changes, skin texture); or absent dorsalis pedis pulse. Class C Findings: Edema, claudication, or temperature changes in the skin. If your documentation for CPT 11720 and 11721 (debridement of nails) does not explicitly link these class findings to the patient's systemic condition, the claim will be denied as a "carve-out" service, regardless of your enrollment status. Surgical Revenue Wins: RVU Increases for Arthrodesis While routine care faces heavy scrutiny, 2026 brings significant wins for podiatric surgeons. The Centers for Medicare & Medicaid Services (CMS) has implemented RVU (Relative Value Unit) increases for several key surgical procedures. Specifically, CPT 28750 (Arthrodesis, great toe; metatarsophalangeal joint) and CPT 28755 (Arthrodesis, great toe; interphalangeal joint) have seen a valuation lift. These RVU increases reflect updated RUC valuations acknowledging the procedural and postoperative complexity. To capitalize on these increases, ensure your Medicare enrollment is up-to-date with your current surgical facility affiliations. Discrepancies between your listed practice locations and the Place of Service (POS) on your claims are a primary trigger for automated denials in 2026. Commercial Panel Quirks: The Shift Toward Continuous Monitoring Commercial payers like Cigna and CareFirst have moved away from traditional three-year re-credentialing cycles. In 2026, the industry has shifted to "Continuous Monitoring." This means these payers are performing monthly automated checks against the National Practitioner Data Bank (NPDB), state licensing boards, and the Office of Foreign Assets Control (OFAC). The biggest hurdle for DPMs today is the "Closed Panel." Many high-reimbursement networks are currently closed to new podiatry providers. However, Veracity has noted that "closed" often simply means "restricted." You can often bypass these restrictions by demonstrating a "Network Gap." If you provide a sub-specialty: such as advanced wound care or pediatric podiatry: that is underrepresented in a specific geographic zip code, you can successfully appeal a panel closure. Monthly Maintenance in CAQH Your CAQH (Council for Affordable Quality Healthcare) profile is your digital passport. Payers now pull data from CAQH on a monthly basis to satisfy their continuous monitoring requirements. If your malpractice insurance expiration date passes without an updated COI (Certificate of Insurance) uploaded to CAQH, your health plan contracts can be suspended within 30 days. This "silent" suspension often goes unnoticed until the first batch of EOBs returns with a "Provider Not Par" denial code. Medicaid and Medi-Cal: The Enrollment Bottleneck For practices in states with heavy Medicaid or Medi-Cal patient volumes, the 2026 enrollment bottleneck is a serious threat. In states where podiatrists bill Medicaid or Medi-Cal and are classified as high-risk for enrollment purposes, these agencies have increased their "site visit" requirements. This applies in state-specific scenarios, including Medi-Cal contexts such as California, rather than as a universal national rule. While podiatrists are generally considered moderate-to-low risk, any practice that also bills for Durable Medical Equipment (DME) like custom orthotics or diabetic shoes can face added enrollment scrutiny depending on state program rules. This requires a physical inspection of your facility to ensure compliance with CMS standards. Failure to pass a site visit: or failing to respond to a site visit request: will result in an immediate termination of your Medicaid ID. This termination often triggers a "cross-termination" clause in your Medicare and commercial contracts, effectively shutting down your practice's ability to bill any insurance. Final Directives for Your 2026 Enrollment Strategy The administrative burden of running a podiatry practice in 2026 is at an all-time high. To protect
